Addressing Bioanalytical Needs of Antibody-Based Biotherapeutics by LC-MS
Antibody-based biotherapeutics are the fastest growing category of therapeutics entering clinical studies [1]. The popularity is attributed to the high selectivity of these drugs which enhances their efficacy and reduces systemic toxicity, in turn, increasing the therapeutic index. In addition, anti...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Betasciencepress Publishers
2020-01-01
|
| Series: | Journal of Applied Bioanalysis |
| Subjects: | |
| Online Access: | https://doi.org/10.17145/jab.20.003 |